Vaccines Export of Germany: Trends and Insights of 2024

Vaccines, the biological preparations produced in healthcare facilities to provide immunity against specific infectious diseases, are preferred more by the topmost global traders due to the public health demand and the limited production locations. The economic valuation of vaccines and the technological transfer and collaborations have contributed to the hike in the global trade of vaccines. Germany Import Data says, the country in Central Europe, bordered by Denmark and Austria in the north and south directions, has established itself as a leading exporter of vaccines in the international trade market due to its strong pharmaceutical manufacturing base and highly skilled workforce engaged in life sciences.

The role of Germany as an attractive pharma production location in the global trade and the technology transfer programs has resulted in an export trade value of vaccines from Germany worth 17 billion US dollars in 2024. The high-quality GMT standards and the strong contract manufacturing have substantially increased the export revenue rate of vaccine exports. Subscribe to Import Globals, the leading Germany importexport trade provider, to stay updated with the latest information regarding the vaccine exports of the nation via the Germany trade data. 

GOVERNMENT INITIATIVES SUPPORTING THE EXPORT OF VACCINES FROM GERMANY IN 2024

The pandemic preparedness contracts have maintained the manufacturing readiness while strengthening the export capacity. The expansion of the mRNA competence center in Hall has boosted the active ingredient production capacity of Germany while promoting higher volumes. 

The BioNTech pandemic preparedness contract has secured high-volume production capability while increasing the ability to supply to the global demand. The technology transfer funding for mRNA production in Africa has strengthened the global vaccine manufacturing capacity for boosting the exports in terms of technology.

THE LEADING VARIANTS OF VACCINES EXPORTED FROM GERMANY IN 2024

The access of the country towards advanced clinical trial infrastructure and the long-term government-industry contracts has eased the efficient transport of diversified production towards the global exporters. According to the Germany Export Data, the top 10 leading variants of vaccines exported from the nation in 2024 are,

  • Inactivated vaccines – The annual valuation of Inactivated vaccines exported from Germany in 2024 – 5.87 billion US dollars
  • Live-attenuated vaccines– The annual valuation of Live-attenuated vaccines exported from Germany in 2024 – 4.25 billion US dollars
  • mRNA vaccines– The annual valuation of mRNA vaccines exported from Germany in 2024 – 2.21 billion US dollars
  • DNA vaccines– The annual valuation of DNA vaccines exported from Germany in 2024 – 1.78 billion US dollars
  • Viral vector vaccines (non-replicating) – The annual valuation of Viral vector vaccines (non-replicating) exported from Germany in 2024 – 1.65 billion US dollars
  • Viral vector vaccines (replicating) – The annual valuation of Viral vector vaccines (replicating) exported from Germany in 2024 – 1.54 billion US dollars
  • Protein subunit vaccines– The annual valuation of Protein subunit vaccines exported from Germany in 2024 – 1.28 billion US dollars
  • Conjugate vaccines– The annual valuation of Conjugate vaccines exported from Germany in 2024 – 1 billion US dollars
  • Polysaccharide vaccines– The annual valuation of Polysaccharide vaccines exported from Germany in 2024 – 987 million US dollars
  • Virus-like particle (VLP) vaccine– The annual valuation of Virus-like particle (VLP) vaccine exported from Germany in 2024 – 827 million US dollars

THE TOP 10 EXPORT TRADE PARTNERS OF GERMANY IN 2024

The high biosecurity standards and the government authorities' commitment to maintain a strong biopharma industry have established suitable bilateral relationships with the topmost traders worldwide. As per the Germany Customs Data, the top 10 export trade partners of the nation for vaccines exported in 2024 are,

  • United States – The annual valuation of vaccines exported from Germany to the United States in 2024 – 3.21 billion US dollars

Top 5 variants of vaccines exported

  • Outer membrane vesicle (OMV) vaccine
  • Bacterial polysaccharide-protein conjugate vaccine
  • Phase separation nanoparticle vaccine
  • Layered double hydroxide (LDH) nanoparticle vaccine
  • Deoxyribozyme-based vaccine
  • France – The annual valuation of vaccines exported from Germany to France in 2024 – 2.98 billion US dollars

Top 5 variants of vaccines exported

  • Recombinant viral-like particle vaccine
  • Synthetic peptide-conjugate vaccine
  • Glycoconjugate vaccine
  • Recombinant toxoid vaccine
  • Heat‑killed bacterial vaccine
  • Netherlands – The annual valuation of vaccines exported from Germany to the Netherlands in 2024 – 2.26 billion US dollars

Top 5 variants of vaccines exported

  • Yeast‑based vaccine
  • Insect‑cell–derived vaccine
  • Mammalian‑cell–derived vaccine
  • Egg-based vaccine
  • Cell-culture–derived vaccine
  • China– The annual valuation of vaccines exported from Germany to China in 2024 – 2.18 1.78 billion US dollars

Top 5 variants of vaccines exported

  • Intranasal vaccine
  • Oral vaccine
  • Transdermal vaccine
  • Sublingual vaccine
  • Edible plant-based vaccine
  • Poland – The annual valuation of vaccines exported from Germany to Poland in 2024 – 1.54 billion US dollars

Top 5 variants of vaccines exported

  • CpG‑adjuvanted vaccine
  • Toll‑like receptor (TLR) agonist‑adjuvanted vaccine
  • Lipid nanoparticle (LNP) vaccine
  • Microneedle vaccine
  • Intradermal vaccine
  • Italy – The annual valuation of vaccines exported from Germany to Italy in 2024 – 1.20 billion US dollars

Top 5 variants of vaccines exported

  • Homologous prime-boost vaccine
  • Adjuvanted vaccine
  • Non‑adjuvanted vaccine
  • Aluminum‑adjuvant vaccine
  • MF59-adjuvanted vaccine
  • United Kingdom – The annual valuation of vaccines exported from Germany to the United Kingdom in 2024 – 1 billion US dollars

Top 5 variants of vaccines exported

  • Chimeric vaccine
  • Epitope‑based vaccine
  • Dendritic-cell–based vaccine
  • DNA prime – protein boost vaccine
  • Heterologous prime-boost vaccine
  • Austria– The annual valuation of vaccines exported from Germany to Austria in 2024 – 919 million US dollars

Top 5 variants of vaccines exported

  • Nano‑particle vaccine
  • Liposome‑based vaccine
  • Virosome vaccine
  • Reverse vaccinology vaccine
  • Reverse genetics vaccine
  • Switzerland– The annual valuation of vaccines exported from Germany to Switzerland in 2024 – 876 million US dollars

Top 5 variants of vaccines exported

  • Peptide vaccine
  • Live bacterial vaccine
  • Bacterial vector vaccine
  • Recombinant viral vaccine
  • Replicon RNA vaccine
  • Belgium – The annual valuation of vaccines exported from Germany to Switzerland in 2024 – 728 million US dollars

Top 5 variants of vaccines exported

  • Virus‑like particle (VLP) vaccine
  • Conjugate vaccine
  • Polysaccharide vaccine
  • Toxoid vaccine
  • Recombinant protein vaccine

Comments

Popular posts from this blog

Overview of the Optical Equipment Import of Vietnam in 2023

An in-depth Analysis of Gold, Nicaragua's Top Export

Seafood Export of Uganda in 2023